Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

A legfontosabb adatok

Ki végzi
Genesis Research LLC
Hol
San Diego (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
4 fő vett részt
Kezdés
2023. máj. 30.
Befejezés
2024. dec. 5.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • TRANBERG®|Thermal Therapy System
A regiszteradat frissítve
2024. december 10.
Miért állt le
Business decision of the Sponsor

Ki vehet részt

Életkor
40 év – 85 év
Nem
Csak férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • Men between the ages of 40 and 85 years
  • Ability to read, understand and agree/sign the patient informed consent in the English language
  • Serum PSA < 20 ng/ml
  • AJCC clinical tumor stage T2b or less (according to digital rectal examination)
  • Men with localized PCa (GG 1or 2, Gleason Score 7 or less) (Low or Favorable Intermediate Risk PCa) with an MR-image detected index lesion done within three months from the time of enrollment and visible on micro-ultrasound
  • According to the decision of the investigator:; Patient is suitable to undergo treatment with FLA; Able to tolerate a procedure under local anesthesia; Able to undergo Nitrous Oxide sedation; Able to undergo MR; has normal rectal anatomy
  • Lesion Specificity:; Unilateral, with cumulative lesion volumes not comprising more than 50 percent of the lobe as determined by MRI; Lesion distances from the outer perimeter of the energy emitting zone of the diffuser to adjacent vital structures (bladder wall, rectal wall, neurovascular bundles, and urethra) must be ≥ 8mm
  • Minimum distance to rectal wall and other sensitive structures ≥ 8mm

Ki nem vehet részt

  • Previous prostate surgery
  • Anticoagulant therapy
  • Prior or ongoing PCa treatment including surgery, radiation therapy, hormonal therapy or focal therapy
  • Previous radiation of the pelvic region
  • Patients with recurrent prostate cancer
  • Gleason Grade Group 3 PCa or higher
  • Multifocal PCa other than Gleason Grade Group 1
  • Locally advanced or metastatic PCa
  • Intraprostatic calculus > 5mm
  • Inability to tolerate a dorsal lithotomy position under Nitrous Oxide sedation for > 90 minutes
  • ECOG Status ≥2
  • Urethral Stenosis
  • Prostate height > 5 cm anterior to posterior or a prostate volume >100 cc's

Helyszínek itt: Egyesült Államok

  • Genesis Research, LLCSan Diego, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

Trans-perineal focal laser ablation represents a promising alternative focal therapy option for patients with low-risk or favorable intermediate risk prostate cancer. FLA has been extensively utilized for over a decade in the treatment of PCa using different anatomical approaches. The proposed study differs from past ones in that a trans-perineal approach with reduced risk of infection will be used in contrast to the current trans-rectal approach. In addition, high frequency micro-ultrasound imaging will be used to enhance imaging and facilitate accurate needle placement and FLA of the index lesions.

A teljes eredeti leírásKevesebb

The aim of this study is to evaluate FLA as a potential optimal therapeutic intervention based on safety, ease of use, efficacy, and cost.1 FLA holds promise for the management of localized tumors. The combination of the trans-perineal focal laser ablation and micro-ultrasound imaging will enable targeted trans-perineal fusion laser induced thermal therapy of prostate cancer lesions. This approach offers significant potential advantages over traditional interventions including:

* Improved dynamic ultrasound imaging of the lesion to be treated compared to traditional ultrasound techniques. * Enhanced ability to visualize and spare critical structures within the prostate, including the bladder neck, neurovascular bundle (NVB), urethral sphincter and organs in close proximity including the rectum. * Sparing these structures should translate into improved preservation of ejaculation, limited changes in sexual function and minimal transient incontinence following treatment.

A vizsgálat csoportja

  • Laser AblationA vizsgált kezelés

    TRANBERG® Transperineal Micro Ultrasound guided laser ablation of Prostate Cancer.

    Kezelés: TRANBERG®|Thermal Therapy System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2024. december 10.